The increased interest in personalised medications, which rely on human tissue removed during surgery to develop novel tests used in patient care, is driving up demand for excised human Tissue Diagnostic Market. With the development of better diagnostic techniques, there is a growing desire for individualised medicine in the treatment of various diseases, including cancer. These technologies help doctors identify and quantify a variety of biomarkers and segment individuals based on various disease and treatment criteria. For the treatment of cancer, several cutting-edge diagnostics are already in use. One of the advanced diagnostics for customised treatment, Oncotype DX, for instance, analyses 21 genes to identify breast cancer patients who can be treated without chemotherapy.
Read more @ https://creativeedge16.blogspot.com/2023/01/tissue-diagnostic-market-global-outlook.html
